Idaho Kidney Center - Blackfoot is a medicare approved dialysis facility center in Blackfoot, Idaho and it has 6 dialysis stations. It is located in Bingham county at 245 Poplar, Blackfoot, ID, 83221. You can reach out to the office of Idaho Kidney Center - Blackfoot at (208) 643-0876. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Idaho Kidney Center - Blackfoot has the following ownership type - Profit. It was first certified by medicare in November, 2006. The medicare id for this facility is 132515 and it accepts patients under medicare ESRD program.
| Name | Idaho Kidney Center - Blackfoot |
|---|---|
| Location | 245 Poplar, Blackfoot, Idaho |
| No. of Dialysis Stations | 6 |
| Medicare ID | 132515 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 245 Poplar, Blackfoot, Idaho, 83221 | |
| (208) 643-0876 | |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
| NPI Number | 1467480582 |
| Organization Name | Idaho Kidney Center-blackfoot |
| Doing Business As | Idaho Kidney Center-blackfoot Llc |
| Address | 245 Poplar St Blackfoot, Idaho, 83221 |
| Phone Number | (208) 643-0876 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 15 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 20 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 36 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 299 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Idaho Kidney Center - Blackfoot with elevated calcium levels.
| Patients with hypercalcemia | 36 |
| Hypercalcemia patient months | 299 |
| Patients with Serumphosphor | 40 |
| Patients with Serumphosphor less than 3.5 mg/dL | 13 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 36 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 36 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 11 |
| Patients with Serumphosphor greater than 7 mg/dL | 4 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 32 |
| Patient months included in arterial venous fistula and catheter summaries | 234 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 67 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 29 |
| Hospitalization Rate in facility | 98.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 234.1 |
| Hospitalization Rate: Lower Confidence Limit | 44 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Idaho Kidney Center - Blackfoot were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 24.6 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 48.1 |
| Readmission Rate: Lower Confidence Limit | 8.9 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Idaho Kidney Center - Blackfoot get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.48 (As Expected) |
| SIR: Upper Confidence Limit | 4.02 |
| SIR: Lower Confidence Limit | .38 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Idaho Kidney Center - Blackfoot's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 28 |
| Transfusion Rate in facility | 25.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 122.6 |
| Transfusion Rate: Lower Confidence Limit | 6.3 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at Idaho Kidney Center - Blackfoot lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 134 |
| Mortality Rate in facility | 13.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.8 |
| Mortality Rate: Lower Confidence Limit | 7.9 |
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago
News Archive
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.
"President Bush stated this week that he intends to veto pending legislation that would reauthorize the State Children's Health Insurance Program (SCHIP), which is set to expire Sept. 30. The bill would extend health coverage to approximately 4 million uninsured children and continue providing coverage to 6 million children.
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.
› Verified 4 days ago